Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement

Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream

Global Aerogels Market Analysis, Trends and Revenue 2018-2020 & 2021-2031 Dublin, March 30, 2021 (GLOBE NEWSWIRE) -- The "The Global Market for Aerogels to 2031" report has been added to ResearchAndMarkets.com's offering. Aerogels can be divided into two broad...